Medicenna Announces Oral Presentation of MDNA11 Data from the Phase 1/2 ABILITY-1 Study at the ...
Oral presentation of MDNA11’s Phase 1/2 ABILITY-1 Study will feature new and updated clinical data
Source: eagletribune.com
Localized Infusion News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Localized Infusion. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Localized Infusion Today - Breaking & Trending Today
Medicenna Therapeutics Corp. Announces A Poster Presentation and an Oral Summary Highlighting Long-term Follow-up Up Results from the Phase 2b Clinical Trial of Bizaxofusp
Medicenna Therapeutics Corp. announced that a poster presentation and an oral summary highlighting longer term follow up results from the Phase 2b clinical trial of bizaxofusp , the Company's...
Source: marketscreener.com
Medicenna to Present 4 Year Follow-up Phase 2b Bizaxofusp
TORONTO and HOUSTON, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTC: MDNAF), a...
Source: globenewswire.com